CANF
Can-Fite BioPharma American Depositary Shares
CANF
CANF
14 hedge funds and large institutions have $429K invested in Can-Fite BioPharma American Depositary Shares in 2026 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
17% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 6
Holders
14
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$176K | |
| 2 | +$141K | |
| 3 | +$80.1K | |
| 4 |
VF
Virtu Financial
New York
|
+$53.4K |
| 5 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$28.2K |
Top Sellers
| 1 | -$193K | |
| 2 | -$5.58K | |
| 3 | -$3.74K | |
| 4 |
BWL
Bogart Wealth LLC
Mclean,
Virginia
|
-$3.01K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$2.42K |
